139 related articles for article (PubMed ID: 38743354)
1. Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance.
O'Brien SF; Ehsani-Moghaddam B; Goldman M; Osmond L; Fan W; Drews SJ
Can J Public Health; 2024 May; ():. PubMed ID: 38743354
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R
Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
Chang YB; Kaidarova Z; Hindes D; Bravo M; Kiely N; Kamel H; Dubay D; Hoose B; Murphy EL
J Infect Dis; 2014 Feb; 209(4):523-31. PubMed ID: 24068702
[TBL] [Abstract][Full Text] [Related]
5. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
6. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
Lee YH; Lu CT; Feng IJ; Hung CM
Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
8. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
Karimi G; Zadsar M; Pourfathollah AA
Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: increased prevalence in one blood bank unit.
Zervou EK; Georgiadou S; Tzilianos M; Georgitsi P; Pournara V; Nousis S; Pappas C; Daskalou L; Vrettou A; Karabini F; Dalekos GN
Eur J Intern Med; 2004 Nov; 15(7):422-427. PubMed ID: 15581745
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar.
Maghsudlu M; Safabakhsh H; Jamili P
Asian J Transfus Sci; 2015; 9(2):203-6. PubMed ID: 26420946
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil: Prevalence, molecular characterization, and evidence of intrafamilial transmission.
Ribeiro IP; Kozlowski AG; Dias de Matos MA; da Costa E Silva ÁM; Dos Santos Carneiro MA; Vicente ACP; Martins RMB
J Med Virol; 2018 Oct; 90(10):1651-1657. PubMed ID: 29797609
[TBL] [Abstract][Full Text] [Related]
13. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Hepatitis B in Canadian First-Time Blood Donors: Association with Social Determinants of Health.
O'Brien SF; Ehsani-Moghaddam B; Goldman M; Drews SJ
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257817
[TBL] [Abstract][Full Text] [Related]
15. Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors.
Hedayati-Moghaddam MR; Tehranian F; Bayati M
Viruses; 2015 Nov; 7(11):5736-45. PubMed ID: 26556363
[TBL] [Abstract][Full Text] [Related]
16. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.
Chang L; Ou S; Shan Z; Zhu F; Ji H; Rong X; Guo F; Jiang X; Sun H; Yan Y; Wang L
Retrovirology; 2021 Jan; 18(1):2. PubMed ID: 33413457
[TBL] [Abstract][Full Text] [Related]
18. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N
Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
